Diabetes drug Actos doubles risk of bladder cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

Singapore: Canadian scientists have revealed that the diabetes drug pioglitazone, also known as Actos, doubles the risk of bladder cancer. However, the researchers found that in absolute te...Read more

Taiwan, China firms to co-develop cancer NCEs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

Singapore: Taiwan's PharmaEngine has collaborated and signed research agreement with China's Guangzhou BeBetter Medicine Technology. The two companies will collaborate to design, synthesize...Read more

Eisai to launch breast cancer drug in India

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

Prana Biotech readies to progress PBT2 to market

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to treat Alzheimer's and Huntington diseases into late stage and pre-mar...Read more

Oramed recruits patients for oral insulin trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insulin capsule,ORMD-0801, for patients with type 1 diabetes mellitus (T1DM...Read more

GlobalData: New Zealand focuses on generics

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Feb, 2013

Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emphasising on generics, despite the disproportionate growth in elderly ...Read more

Allied to soon get CE mark approval from EU

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approval for CardioCel, its lead regenerative tissue product for the repair ...Read more

Rockefeller University finds genetic link to autism

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed the precise genetic footprint that links fragile X syndrome and autism...Read more

GSK, Theravance COPD drug gets FDA nod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Apr, 2013

Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Theravance's Breo Ellipta as a once-daily inhaled treatment for the long-te...Read more

Bayer gets Japan's nod for gastro tumor drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastrointestinal stromal tumor (GIST) who have progressed following prior ...Read more

Theravance, Alfa Wassermann collaborate

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in certain countries for velusetrag, Theravance's investigational 5-HT4 agon...Read more

Epilepsy Foundation asks DEA to better review process

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process for reviewing new treatments, which currently lack innovation and tra...Read more

Fight against TB needs $1.6 bn funding annually

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2013

Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at l...Read more

Daiichi to aid drug discovery projects

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project for 2013. The company will select research partners for the proj...Read more

Queensland to get a new drug development center

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk announced the establishment of the University of Queensland Emory Drug D...Read more

FDA follows EU, declares Patrys drug as 'orphan'

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from t...Read more

AbbVie, Galapagos to make drugs for cystic fibrosis mutations

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an in...Read more

Mylan to produce generic of Gilead's HIV drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top this agreement, Mylan licensed the rights to produce and market generic ...Read more